Valerian for anxiety disorder
References
Additional references
Almeida‐Filho N, Mari JJ, Coutinho E, Franca JF, Fernandes J, Andreoli SB, et al. Brazilian multicentric study of psychiatric morbidity. Methodological features and prevalence estimates. British JOurnal of Psychiatry 1997;171:524‐9.
Bijl RV, Ravelli A, van Zessen G. Prevalence of Psychiatric disorder in the general population: Results of the Netherland Mental Health Survey and Incidence Study (NEMESIS). Social Psychiatry & Psychiatric Epidemiology 1998;33(12):587‐95.
Borkovec TD, Mathews AM, Chambers AM, Ebrahimi S, Lytle R, Nelson R, et al. The effects of relaxation training with cognitive or nondirective therapy and the role of relaxation‐induced anxiety in the treatment of generalized anxiety disorder. Journal of Consulting & Clinical Psychology 1987;55(6):883‐8.
Borkovec TD, Costello E. Efficacy of applied relaxation and cognitive behavioral therapy in the treatment of generalized anxiety disorder. Journal of Consulting & Clinical Psychology 1993;61(4):611‐9.
Clarke M, Oxman AD. Cochrane Collaboration Handbook. Oxford: Update Software, 2000.
Donath F, Quispe S, Diefenbach K, Maurer A, Fietze I, Roots I. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry 2000;33(2):47‐53.
Gould RA, Otto MW, Pollack MH, Yap L. Cognitive behavioural and pharmacological treatment of generalized anxiety disorders: Preliminary meta‐analysis. Behavior THerapy 1997;28(2):285‐305.
Hendriks H, Bos R, Allersma DP, Malingre TM, Koster AS. Pharmacological screening of valerenal and some other components of essential oil of Valeriana officinalis. Planta Medica 1981;42(1):62‐8.
Jadad AR, Moore RA, Carrol D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of reports of randomized clinical trials: is blinding necessary?. Controlled Clinical Trials 1996;17(1):1‐12.
Kapczinski F, Margis R, Busnello JV, Isolan L, Quevedo J, Gale C, et al. Psychotherapy for generalized anxiety disorder. Cochrane Library 2003, Issue 1.
Kessler RC, McGonagle KA, Zhao S, Nelson CB, Hughes M, Eshleman S, et al. Lifetime and 12 month prevalence of DSM III R psychiatric disorders in United States. Archives of General Psychiatry 1994;51(1):8‐19.
Leathwood PD, Chauffard F. Aqueous extract of valerian reduces latency to fall asleep in man. Planta Medica 1985;51(2):144‐8.
Mayer B, Springer E. Psychoexperimental studies on the effect of a valepotriate combination as well as the combined effects of valtratum and alcohol [Psyschoexperimentelle untersuchungen zur wirking einer Valepotriatkombination sowie zur Kombinierten wirkung von Valtratum und Alkohol]. Arzneimittel‐Forschung 1974;24(12):2066‐70.
Mendlowicz MV, Stein MB. Quality of life in individuals with anxiety disorders. American Journal of Psychiatry 2000;157(6):669‐82.
Mennini T, Bernasconi P, Bombardelli E, Morazzoni P. In vitro study on the interaction of extracts and pure compounds from Valeriana officinalis roots with GABA, benzodiazepine and barbiturate receptors in rat brain. Fitoterapia 1993;64(4):291‐300.
Petkov VD, Manolov PN, Marekov NL, Popov SS, Handjieva NB. Pharmacological studies on a mixture of valepotrietes isolated from Valeriana officinalis. Doklady Bolgarskoi Akademii Nauk 1974;27:1007‐10.
Pittler MH, Ernst E. Kava extract for treating anxiety. Cochrane Library 2002, Issue 3.
Priest RG, Montgomery SA, Priest RG, Montgomery SA. Benzodiazepines and dependance: a college statement. Bulletin of the Royal College of Psychiatrists 1988;12:107‐08.
Schmidt‐Voigt J. Treatment of nervous sleep disorders and unrest with a sedative of purely vegetable origin [Die Behandlung nervoser Schfstorungen und innerer Unruhe mit einem rein pflanzlichen Sedativum]. Therapiewoche 1986;36(7):663‐7.
Schulz KF, Chalmmers I, Haves RJ, Altman DG. Empirical evidence of bias: Dimension of methodological quality associated with estimates of treatment effects in controlled trials. Jama 1995;273(5):408‐12.
Taylor CB. In: Agras WS editor(s). Relaxation training and related techniques in behavioural modifications: Principles and clinical applications. Boston, MA: Little Brown, 1978.
Taylor CB, Arnow B. The nature and the treatment of anxiety disorders. New York, NY: Free Press, 1988.
Von Eickstedt KW, Rahman S. Psychopharmacologic effect of valepotriates [Psychopharmakologische Wirkungen von Valepotriaten]. Arzneimittel‐Forschung 1969;19(3):316‐9.
Vorbach EU, Gortelmeyer R, Bruning J. Therapy of insomnia. The efficacy and tolerability of valerian [Therapie von Insomnien. Wirksamkeit und Vertraglichkeit eines Baldrianpraparats]. Psychopharmakotherapie 1996;3(3):109‐15.
Walley EJ, Beebe DK, Clark JL. Management of commom anxiety disorders. American Family Physician 1994;50(8):1745‐53.
